Anti‐Glioma Activity of Artejasminolide Isolated From Artemisia argyi Based on Bioactivity Evaluation and Network Pharmacology

= 5.6 µM) and potently abrogated cell migration and invasion in a dose-proportional manner by suppressing PI3K/AKT/mTOR phosphorylation, as confirmed by Transwell and Western blot analyses. Bioinformatics analysis further suggested EGFR as a potential upstream target mediating these effects. These findings indicated A. argyi as a possible source of bioactive terpenoids with anti-glioma potential, providing a theoretical basis for further pharmacological studies.